{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:11:38Z","timestamp":1794852698139,"version":"4.9.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) is a major public health concern due to its association with increased cardiovascular risk. Patients with CKD, especially those with moderate to severe renal dysfunction, face a heightened risk of cardiovascular events and mortality. This systematic review evaluates the relationship between CKD and cardiovascular risk, focusing on the pathophysiology, risk factors, and clinical outcomes related to cardiovascular disease (CVD) in CKD populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive search of electronic databases was conducted for studies investigating CKD and cardiovascular risk. Seven studies, including cross-sectional, and cohort designs, were included in this review. These studies involved a total of 104,576 participants, with diverse stages of CKD and varying cardiovascular risk profiles. Data on renal dysfunction stages, cardiovascular risk factors, and mortality outcomes were extracted and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The studies consistently demonstrated that CKD is associated with an increased risk of cardiovascular events, including coronary heart disease and stroke, compared to individuals without CKD. Even early stages of CKD were linked to a higher likelihood of CVD. Participants with CKD exhibited a greater burden of traditional cardiovascular risk factors, including hypertension, diabetes, dyslipidemia, and obesity. The overall mortality rate from cardiovascular causes was also higher in CKD patients, with some studies reporting a two-fold or greater increase in risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CKD is strongly linked to an increased cardiovascular risk, with higher stages of renal dysfunction associated with a more significant risk of cardiovascular morbidity and mortality. This review emphasizes the need for early detection and comprehensive management of cardiovascular risk factors in CKD patients. Future research should focus on identifying novel biomarkers and evaluating the long-term efficacy of emerging therapies in reducing cardiovascular risk in CKD populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046189","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:01:34Z","timestamp":1764972094000},"page":"e46189","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Chronic kidney disease and cardiovascular risk: Pathophysiology and interventional approaches \u2013 systematic review"],"prefix":"10.1097","volume":"104","author":[{"given":"Muhammad Bari","family":"Hassan","sequence":"first","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Siddique","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Kumar","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fnu","family":"Neelam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fnu","family":"Neha","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Lohana","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Lohana","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bismillah Athar","family":"Dar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Pawan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitara","family":"Jabeen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Umair","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Karim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaghum","family":"Abbas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugal","family":"Kishore","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3310-5442","authenticated-orcid":false,"given":"Abida","family":"Parveen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ki.5002343","article-title":"Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes.","volume":"72","author":"Levey","year":"2007","journal-title":"Kidney Int"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","article-title":"Chronic kidney disease and cardiovascular disease: is there any relationship?","volume":"15","author":"Vallianou","year":"2019","journal-title":"Curr Cardiol Rev"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/jcm13030678","article-title":"Risk factors of chronic kidney disease progression: between old and new concepts.","volume":"13","author":"Mallamaci","year":"2024","journal-title":"J Clin Med"},{"key":"R4-20260523","first-page":"e51362","article-title":"Navigating the crossroads: understanding the link between chronic kidney disease and cardiovascular health.","volume":"15","author":"Saeed","year":"2023","journal-title":"Cureus"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ecl.2017.10.006","article-title":"Managing diabetes and cardiovascular risk in chronic kidney disease patients.","volume":"47","author":"Lovre","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2362.2007.01840.x","article-title":"Mineral metabolism disturbances in patients with chronic kidney disease.","volume":"37","author":"Kestenbaum","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"R7-20260523","first-page":"99","article-title":"The link between chronic kidney disease and cardiovascular disease.","volume":"3","author":"Said","year":"2014","journal-title":"J Nephropathol"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of hypertension in chronic kidney disease.","volume":"79","author":"Pugh","year":"2019","journal-title":"Drugs"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.3399\/bjgp20X714125","article-title":"Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care.","volume":"71","author":"MacRae","year":"2021","journal-title":"Br J Gen Pract"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jcmg.2012.06.007","article-title":"Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.","volume":"5","author":"Murthy","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/S2214-109X(16)00071-1","article-title":"Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.","volume":"4","author":"Ene-Iordache","year":"2016","journal-title":"Lancet Glob Health"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/j.1523-1755.2005.09308.x","article-title":"Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD).","volume":"93","author":"Goicoechea","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","article-title":"Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.","volume":"293","author":"Shlipak","year":"2005","journal-title":"JAMA"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"c4986","DOI":"10.1136\/bmj.c4986","article-title":"Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study.","volume":"341","author":"Di Angelantonio","year":"2010","journal-title":"BMJ"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.5551\/jat.63891","article-title":"Cardiovascular risk factor burden and treatment control in patients with chronic kidney disease: a cross-sectional study.","volume":"30","author":"Kitamura","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/archinte.166.17.1884","article-title":"Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.","volume":"166","author":"Parikh","year":"2006","journal-title":"Arch Intern Med"},{"key":"R17-20260523","first-page":"2918","article-title":"Cardiovascular disease and its relationship with chronic kidney disease.","volume":"18","author":"Liu","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00109-021-02037-7","article-title":"Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.","volume":"99","author":"D\u00fcsing","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"949260","DOI":"10.3389\/fphar.2022.949260","article-title":"Hypertension in chronic kidney disease: what lies behind the scene.","volume":"13","author":"Ameer","year":"2022","journal-title":"Front Pharmacol"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4093\/dmj.2023.0067","article-title":"Dyslipidemia in patients with chronic kidney disease: an updated overview.","volume":"47","author":"Suh","year":"2023","journal-title":"Diabetes Metab J"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/ijms23010531","article-title":"Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review.","volume":"23","author":"Harlacher","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5527\/wjn.v1.i1.25","article-title":"Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease.","volume":"1","author":"Nemcsik","year":"2012","journal-title":"World J Nephrol"},{"issue":"Suppl B","key":"R24-20260523","first-page":"22B","article-title":"Chronic kidney disease, heart failure and anemia.","volume":"24","author":"Virani","year":"2008","journal-title":"Can J Cardiol"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.123.321760","article-title":"Cardiovascular calcification heterogeneity in chronic kidney disease.","volume":"132","author":"Hutcheson","year":"2023","journal-title":"Circ Res"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"100705","DOI":"10.1016\/j.xkme.2023.100705","article-title":"Heart failure with preserved ejection fraction with CKD: a narrative review of a multispecialty disorder.","volume":"5","author":"Patel","year":"2023","journal-title":"Kidney Med"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.ackd.2014.06.007","article-title":"The interplay between CKD, sudden cardiac death, and ventricular arrhythmias.","volume":"21","author":"Pun","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"1101068","DOI":"10.3389\/fphar.2023.1101068","article-title":"Renin-angiotensin-aldosterone pathway modulators in chronic kidney disease: a comparative review.","volume":"14","author":"Alshahrani","year":"2023","journal-title":"Front Pharmacol"},{"key":"R29-20260523","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3390\/ijerph15122733","article-title":"Statins and cardiovascular disease outcomes in chronic kidney disease: reaffirmation vs. repudiation.","volume":"15","author":"Obialo","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"R30-20260523","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.7326\/M21-0893","article-title":"Sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes across categories of cardiovascular disease.","volume":"174","author":"Patorno","year":"2021","journal-title":"Ann Intern Med"},{"issue":"Suppl 11","key":"R31-20260523","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/17.suppl_11.16","article-title":"Hyperphosphataemia as a cardiovascular risk factor -- how to manage the problem.","volume":"17","author":"Cannata-And\u00eda","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R32-20260523","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/jcm13020486","article-title":"Dietary salt restriction and adherence to the Mediterranean diet: a single way to reduce cardiovascular risk?","volume":"13","author":"D\u2019Elia","year":"2024","journal-title":"J Clin Med"},{"key":"R33-20260523","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease.","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"key":"R34-20260523","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/toxins12120812","article-title":"Uremic vascular calcification: the pathogenic roles and gastrointestinal decontamination of uremic toxins.","volume":"12","author":"Chao","year":"2020","journal-title":"Toxins (Basel)"},{"key":"R35-20260523","doi-asserted-by":"crossref","first-page":"e240427","DOI":"10.1001\/jamanetworkopen.2024.0427","article-title":"Representation of patients with chronic kidney disease in clinical trials of cardiovascular disease medications: a systematic review.","volume":"7","author":"Colombijn","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R36-20260523","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ekir.2022.04.094","article-title":"Prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations.","volume":"7","author":"Yau","year":"2022","journal-title":"Kidney Int Rep"},{"key":"R37-20260523","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/HJH.0000000000003563","article-title":"Lifestyle management of hypertension: international society of hypertension position paper endorsed by the world hypertension league and European Society of Hypertension.","volume":"42","author":"Charchar","year":"2024","journal-title":"J Hypertens"},{"key":"R38-20260523","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MNH.0b013e328327b360","article-title":"Mechanisms for increased cardiovascular disease in chronic kidney dysfunction.","volume":"18","author":"Yamamoto","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R39-20260523","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pop.2008.01.008","article-title":"Chronic kidney disease and its complications.","volume":"35","author":"Thomas","year":"2008","journal-title":"Prim Care"},{"key":"R40-20260523","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.kisu.2017.07.006","article-title":"Closing the gap between evidence and practice in chronic kidney disease.","volume":"7","author":"Jardine","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"R41-20260523","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases.","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:01:04Z","timestamp":1779530464000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":41,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046189","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-05-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}